| P2093 | author name string | Jun Yao | |
| | Xin Zhang | |
| | Yong Liang | |
| | Zhiqiang Zhao | |
| | Cuijuan Qian | |
| | Ting Shu | |
| P2860 | cites work | The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 |
| | Notch signalling: a simple pathway becomes complex | Q29555851 |
| | Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells | Q33235983 |
| | Sudan black B reduces autofluorescence in murine renal tissue | Q34039626 |
| | Hath1 up-regulates gastric mucin gene expression in gastric cells | Q34519056 |
| | High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer. | Q34548034 |
| | The Notch signalling system: recent insights into the complexity of a conserved pathway | Q35206852 |
| | Notch signaling in gastrointestinal tract (review). | Q36672806 |
| | Crossing paths with Notch in the hyper-network | Q36743025 |
| | Wnt/Notch signalling and information processing during development. | Q37055994 |
| | Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK | Q37269941 |
| | Pathological roles of MAPK signaling pathways in human diseases | Q37676393 |
| | The role of Wnt/beta-catenin signaling in renal carcinogenesis: lessons from cadmium toxicity studies | Q37747510 |
| | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 |
| | Notch signalling in cancer progression and bone metastasis | Q37954986 |
| | Notch post-translationally regulates β-catenin protein in stem and progenitor cells | Q38635489 |
| | Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation | Q38802972 |
| | ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism | Q39316942 |
| | Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer | Q39411477 |
| | Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers | Q39564265 |
| | BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus. | Q39586177 |
| | Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors | Q42473171 |
| | Establishment and characterization of a SV40 transformed human fetal gastric epithelial cell line-GES-1 | Q42807384 |
| | PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response | Q45038180 |
| | Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models. | Q51824498 |
| | ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer. | Q54451018 |
| P433 | issue | 9 | |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 833-839 | |
| P577 | publication date | 2013-06-14 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | Combination treatment of PD98059 and DAPT in gastric cancer through induction of apoptosis and downregulation of WNT/β-catenin | |
| P478 | volume | 14 | |